PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Demir, M.* ; Bornstein, S.R. ; Mantzoros, C.S.* ; Perakakis, N.

Liver fat as risk factor of hepatic and cardiometabolic diseases.

Obes. Rev. 24:e13612 (2023)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Non-alcoholic fatty liver disease (NAFLD) is a disorder characterized by excessive accumulation of fat in the liver that can progress to liver inflammation (non-alcoholic steatohepatitis [NASH]), liver fibrosis, and cirrhosis. Although most efforts for drug development are focusing on the treatment of the latest stages of NAFLD, where significant fibrosis and NASH are present, findings from studies suggest that the amount of liver fat may be an important independent risk factor and/or predictor of development and progression of NAFLD and metabolic diseases. In this review, we first describe the current tools available for quantification of liver fat in humans and then present the clinical and pathophysiological evidence that link liver fat with NAFLD progression as well as with cardiometabolic diseases. Finally, we discuss current pharmacological and non-pharmacological approaches to reduce liver fat and present open questions that have to be addressed in future studies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
8.900
0.000
2
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Cardiovascular ; Diabetes ; Obesity ; Steatosis; Controlled Attenuation Parameter; Exome-wide Association; Nonalcoholic Steatohepatitis; Insulin-resistance; Diagnostic-accuracy; External Validation; Triglyceride Levels; Bariatric Surgery; Total Cholesterol; Weight-loss
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 1467-7881
e-ISSN 1467-789X
Zeitschrift Obesity Reviews
Quellenangaben Band: 24, Heft: 10, Seiten: , Artikelnummer: e13612 Supplement: ,
Verlag Blackwell
Verlagsort Oxford
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Pancreatic Islet Research (IPI)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502600-012
G-502600-007
Förderungen Deutsche Forschungsgemeinschaft
Bundesministerium fuer Bildung und Forschung
DOI 10.1111/obr.13612
WOS ID 001044110500001
Scopus ID 85166939208
PubMed ID 37553237
Erfassungsdatum 2023-10-06
[➜Korrektur melden]